Israel Down Syndrome Market to 2032

Overview

The Israel Down Syndrome Market is expected to reach a 5.97 USD Million by 2032 and is projected to grow at a CAGR of 15.93% from 2025 to 2032.

Revenue, 2024 (USD Million)
2.74
Forecast, 2032 (USD Million)
5.97
CAGR, 2024 - 2032
15.93%
Report Coverage
Israel

Israel Down Syndrome Market 2018-2032 USD Million

Israel Down Syndrome Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 2.74 USD Million
  • Projected Market Size (2032): 5.97 USD Million
  • CAGR (2025-2032): 15.93%

Key Findings of Israel Down Syndrome Market

  • The Israel Down Syndrome Market was valued at 2.74 USD Million in 2024.
  • The Israel Down Syndrome Market is likely to grow at a CAGR of 15.93% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Trisomy 21 in Disease Type Segment accounted for the largest share of the market with a revenue of 2.54 USD Million
  • The fastest growing segment Therapy Centers in End User Segment grew Fastest with a CAGR of 19.74% during the forecast period from 2024 to 2032.

Israel Down Syndrome Market Scope

Israel Down Syndrome Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Therapy Centers
  • Homecare Setting
  • Clinics
  • Hospital
Treatment
  • Therapy
  • Diagnosis
Disease Type
  • Mosaic Down Syndrome
  • Translocation Down Syndrome
  • Trisomy 21

Israel Down Syndrome Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 2.74 USD Million
Market Value in 2032 5.97 USD Million
CAGR (2025-2032) 15.93%
Historic Data 2016-2023
Market Segments Covered Distribution Channel, End User, Treatment, Disease Type

Regional Insights:

  • Leading Market (2024-2032): Israel, leading in terms of revenue 2.74 USD Million in 2024
    • Key Country: Israel, leading in terms of revenue with value of 2.74 USD Million in 2024.

Segments and Scope

  • Israel Down Syndrome Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Israel Down Syndrome Market to 2032 with a revenue of 1.86 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Israel Down Syndrome Market to 2032 with a Growth rate of 17.94 % in forecast period 2025-2032.
  • Israel Down Syndrome Market to 2032, By End User
    • Hospital is the largest segment in Israel Down Syndrome Market to 2032 with a revenue of 1.55 USD Million in the year 2024.
    • Therapy Centers is the Fastest growing segment in Israel Down Syndrome Market to 2032 with a Growth rate of 15.46 % in forecast period 2025-2032.
  • Israel Down Syndrome Market to 2032, By Treatment
    • Diagnosis is the largest segment in Israel Down Syndrome Market to 2032 with a revenue of 2.35 USD Million in the year 2024.
    • Therapy is the Fastest growing segment in Israel Down Syndrome Market to 2032 with a Growth rate of 15.54 % in forecast period 2025-2032.
  • Israel Down Syndrome Market to 2032, By Disease Type
    • Trisomy 21 is the largest segment in Israel Down Syndrome Market to 2032 with a revenue of 2.54 USD Million in the year 2024.
    • Trisomy 21 is the Fastest growing segment in Israel Down Syndrome Market to 2032 with a Growth rate of 16.24 % in forecast period 2025-2032.

Israel Down Syndrome Market Company Share Analysis

 
Company Name Company Share Analysis
Myriad Genetics, Inc.
PerkinElmer Inc.
Illumina, Inc.
Thermo Fisher Scientific Inc.
Abbott
Israel Down Syndrome Market Company Share Analysis

Israel Down Syndrome Market Geographical Sales Distribution, 2018-2032 USD Million

Israel Down Syndrome Market Geographical Sales Distribution, 2018-2032 USD Million

Israel Down Syndrome Market Company Profiling

Israel Down Syndrome Market Company Profiling
Frequently Asked Questions
The Israel Down Syndrome Market is segmented based on Segmentation Distribution Channel, End User, Treatment, Disease Type.
Israel Down Syndrome Market was valued at USD 2.74(Revenue in USD Million) in 2020.
Israel Down Syndrome Market is projected to grow at a CAGR of 15.93% during the forecast period of 2024 to 2032.
The Trisomy 21 segment is expected to dominate the Israel Down Syndrome Market, holding a largest market share of 2.54 USD Million in 2024

Israel Down Syndrome Market Scope

Israel Down Syndrome Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Therapy Centers
  • Homecare Setting
  • Clinics
  • Hospital
Treatment
  • Therapy
  • Diagnosis
Disease Type
  • Mosaic Down Syndrome
  • Translocation Down Syndrome
  • Trisomy 21
Frequently Asked Questions
The Israel Down Syndrome Market is segmented based on Segmentation Distribution Channel, End User, Treatment, Disease Type.
Israel Down Syndrome Market was valued at USD 2.74(Revenue in USD Million) in 2020.
Israel Down Syndrome Market is projected to grow at a CAGR of 15.93% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Down Syndrome Market for final year is USD 5.97 (USD Million).

Israel Down Syndrome Market Company Profiling

Israel Down Syndrome Market Company Profiling
Frequently Asked Questions
The Israel Down Syndrome Market is segmented based on Segmentation Distribution Channel, End User, Treatment, Disease Type.
Israel Down Syndrome Market was valued at USD 2.74(Revenue in USD Million) in 2020.
Israel Down Syndrome Market is projected to grow at a CAGR of 15.93% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Down Syndrome Market for final year is USD 5.97 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.